A Woman's Heart: Improving Uptake and Awareness of Cardiovascular Screening for Middle-Aged Populations
- PMID: 37520181
- PMCID: PMC10377626
- DOI: 10.2147/IJWH.S328441
A Woman's Heart: Improving Uptake and Awareness of Cardiovascular Screening for Middle-Aged Populations
Abstract
Mid-life, the years leading up to and following the menopause transition, in women is accompanied by a change in cardiometabolic risk factors, including increases in body weight, changes in body composition, a more insulin-resistant state, and a shift towards a more atherogenic dyslipidemia pattern. Cardiovascular disease (CVD) risk assessment should be performed continually throughout the lifespan, as risk is not stagnant and can change throughout the life course. However, mid-life is a particularly important time for a woman to be evaluated for CVD risk so that appropriate preventive strategies can be implemented. Along with assessing traditional risk factors, ascertainment of a reproductive history is an integral part of a comprehensive CVD risk assessment to recognize unique female-specific or female-predominant factors that modify a woman's risk. When there is uncertainty about CVD risk and the net benefit of preventive pharmacotherapy interventions (such as statins), measuring a coronary artery calcium score can help further refine risk and guide shared decision-making. Additionally, there should be heightened sensitivity around identifying signs and symptoms of ischemic heart disease in women, as these may present differently than in men. Ischemia from coronary microvascular disease and/or vasospasm may be present even without obstructive coronary artery disease and is associated with a heightened risk for major cardiovascular events and reduced quality of life. Therefore, correctly identifying CVD in women and implementing preventive and treatment therapies is paramount. Unfortunately, women are underrepresented in cardiovascular clinical trials, and more data are needed about how to best incorporate novel and emerging risk factors into CVD risk assessment. This review outlines an approach to CVD screening and risk assessment in women using several methods, focusing on the middle-aged population.
Keywords: cardiovascular disease; menopause; mid-life; prevention; risk assessment; women’s health.
© 2023 Kazzi et al.
Conflict of interest statement
Dr. Michos has served as a consultant for Amgen, Amarin, AstraZeneca, Bayer, Boehringer Ingelheim, Edwards Life Science, Esperion, Medtronic, Novartis, Novo Nordisk, and Pfizer. Dr. Sierra-Galan has served as a speaker for Pfizer. Dr Lale S Tokgözoğlu reports personal fees from Abbott, Amgen, AstraZeneca, Bayer, Daiichi Sankyo, MSD, Mylan, Novartis, NovoNordisk, Sanofi, Servier, Pfizer, and Recordati, outside the submitted work. The other authors have nothing to disclose for this work.
Figures
Similar articles
-
Menopause Transition and Cardiovascular Disease Risk: Implications for Timing of Early Prevention: A Scientific Statement From the American Heart Association.Circulation. 2020 Dec 22;142(25):e506-e532. doi: 10.1161/CIR.0000000000000912. Epub 2020 Nov 30. Circulation. 2020. PMID: 33251828 Review.
-
Updates in Cardiovascular Disease Prevention, Diagnosis, and Treatment in Women.Med Clin North Am. 2023 Mar;107(2):285-298. doi: 10.1016/j.mcna.2022.10.008. Med Clin North Am. 2023. PMID: 36759098 Review.
-
Sex-specific differences in cardiovascular risk factors and implications for cardiovascular disease prevention in women.Atherosclerosis. 2023 Nov;384:117269. doi: 10.1016/j.atherosclerosis.2023.117269. Epub 2023 Sep 4. Atherosclerosis. 2023. PMID: 37752027 Free PMC article. Review.
-
The Canadian Women's Heart Health Alliance Atlas on the Epidemiology, Diagnosis, and Management of Cardiovascular Disease in Women - Chapter 4: Sex- and Gender-Unique Disparities: CVD Across the Lifespan of a Woman.CJC Open. 2021 Sep 25;4(2):115-132. doi: 10.1016/j.cjco.2021.09.013. eCollection 2022 Feb. CJC Open. 2021. PMID: 35198930 Free PMC article. Review.
-
Update on sex specific risk factors in cardiovascular disease.Front Cardiovasc Med. 2024 Feb 6;11:1352675. doi: 10.3389/fcvm.2024.1352675. eCollection 2024. Front Cardiovasc Med. 2024. PMID: 38380176 Free PMC article. Review.
Cited by
-
Association of Kidney Function With 10-Year Risk of Atherosclerotic Cardiovascular Disease, Cardiovascular Disease and Its Risk Factors Among Women With Type 2 Diabetes Mellitus.Int J Womens Health. 2025 Feb 18;17:449-457. doi: 10.2147/IJWH.S485470. eCollection 2025. Int J Womens Health. 2025. PMID: 39990930 Free PMC article.
-
Cardiovascular Risk Factors and Diseases and Awareness of Related Burden in Women: Results of a Survey in Italian Pharmacies.High Blood Press Cardiovasc Prev. 2025 Mar;32(2):191-198. doi: 10.1007/s40292-025-00701-4. Epub 2025 Feb 6. High Blood Press Cardiovasc Prev. 2025. PMID: 39913084 Free PMC article.
-
Presentation, management, and clinical outcomes of acute type A dissection: Does sex matter?JTCVS Open. 2024 Dec 16;24:47-57. doi: 10.1016/j.xjon.2024.12.006. eCollection 2025 Apr. JTCVS Open. 2024. PMID: 40309714 Free PMC article.
-
Female-Specific Considerations in Aortic Health and Disease.CJC Open. 2023 Sep 15;6(2Part B):391-406. doi: 10.1016/j.cjco.2023.09.006. eCollection 2024 Feb. CJC Open. 2023. PMID: 38487044 Free PMC article. Review.
-
Psychological Health and Ischemic Heart Disease in Women: A Review of Current Evidence and Clinical Considerations across the Healthspan.Curr Atheroscler Rep. 2024 Mar;26(3):45-58. doi: 10.1007/s11883-023-01185-0. Epub 2024 Jan 19. Curr Atheroscler Rep. 2024. PMID: 38240928 Free PMC article. Review.
References
-
- Curtin SC. Trends in cancer and heart disease death rates among adults aged 45–64: United States, 1999–2017. Natl Vital Stat Rep. 2019;68(5):1–9. - PubMed
Publication types
LinkOut - more resources
Full Text Sources